Product Description: Mal-PEG8-Phe-Lys-PAB-Exatecan (compound 15) is a agent-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan (HY-13631) composition[1].
Applications: Cancer-programmed cell death
Formula: C73H92FN9O20
References: [1]Manel KRAIEM. Treatment of cancer. Patent WO2021151984A1.
CAS Number: 2679821-44-2
Molecular Weight: 1434.56
Research Area: Cancer
Solubility: DMSO : 180 mg/mL (ultrasonic)
Target: Drug-Linker Conjugates for ADC;Topoisomerase